Objectives This systematic review aimed to assess the role of magnetic resonance imaging
(MRI) in evaluating residual disease extent and the ability to detect pathologic complete …

Simple Summary Neoadjuvant chemotherapy (NACT) indications have expanded from
inoperable locally advanced to early-stage breast cancer. The pivotal role of magnetic …

Background There is an increasing need to develop a more accurate prediction model for
pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast …

Background Neoadjuvant-chemotherapy (NAC) is considered the standard treatment for
locally advanced breast carcinomas. Accurate assessment of disease response is …

Neoadjuvant therapy is increasingly being used to treat early-stage triple-negative and
human epidermal growth factor 2–overexpressing breast cancers, as well as locally …

Background The main purpose was to investigate the correlation between magnetic
resonance imaging (MRI)-based response patterns halfway through neoadjuvant …

The goals of imaging after neoadjuvant therapy for breast cancer are to monitor the
response to therapy and facilitate surgical planning. MRI has been found to be more …

This review aims to identify factors causing heterogeneity in breast DWI–MRI and their
impact on its value for identifying breast cancer patients with pathological complete …

Nowadays, the decision of which adjuvant treatment should be given to patients with
residual breast cancer after neoadjuvant therapy is based on the initial, pretreatment breast …

The objective of this study is to analyze magnetic resonance imaging shrinkage pattern of
tumor regression after neoadjuvant chemotherapy and to evaluate its relationship with …